Axon Enterprise, Inc (NASDAQ:AXON) Stock Has Consensus Target Price of $688.38 According to Analysts

Shares of Axon Enterprise, Inc (NASDAQ:AXON) have been assigned a consensus recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $612.18.

Several equities research analysts have weighed in on AXON shares. Northland Securities set a $540.00 price target on shares of Axon Enterprise in a research note on Friday, November 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Tuesday, November 3rd. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 price target on the stock. in a report on Friday, November 6th. Morgan Stanley increased their target price on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Finally, Raymond James Financial set a $675.00 price target on shares of Axon Enterprise in a report on Thursday, October 15th.

Axon Enterprise Stock Performance

Shares of AXON opened at $307.11 on Friday. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76. The firm’s fifty day simple moving average is $422.24 and its two-hundred day simple moving average is $469.16. Axon Enterprise has a 12 month low of $291.45 and a 12 month high of $665.07. The stock has a market capitalization of $25.01 billion, a P/E ratio of 98.43, a price-to-earnings-growth ratio of 5.99 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same period in the prior year, the firm earned $1.17 earnings per share. The firm’s revenue for the quarter was up 27.8% compared to the same quarter last year. As a group, analysts predict that Axon Enterprise will post 2.10 EPS for the current year.

Insider Transactions at Axon Enterprise

In related news, CEO Patrick Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 37,397 shares of company stock worth $21,234,034 over the last 90 days. 4.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors have recently made changes to their positions in the stock. State Street Corp lifted its holdings in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. BlackRock Inc. grew its stake in Axon Enterprise by 4.3% during the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after acquiring an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Axon Enterprise by 5,022.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock worth $1,802,719,000 after purchasing an additional 4,183,302 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

More Axon Enterprise News

These are some of the AXON news items that stood out recently:

• Positive Sentiment: Maryland’s Howard County Police Department adopted Axon’s drone-as-first-responder solutions, including Skydio X10 drones, counter-drone technology and AI tools. The deployment supports Axon’s public-safety technology demand, though no contract value was disclosed. Article: Axon Air Drone as First Responder Program Soars into Howard County, Maryland
• Negative Sentiment: Axon’s third-quarter adjusted EPS was reported below consensus, and revenue of $908.55 million also trailed estimates of $934.33 million. Revenue nevertheless grew 27.8% year over year. The earnings shortfall is a key reason for the shares’ recent weakness; Barclays has also lowered its expectations for the stock. Article: Levi & Korsinsky Investigation Notice Article: Barclays Lowers Expectations for Axon
• Negative Sentiment: Two law firms publicized investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add legal uncertainty and could keep investor attention on the earnings miss. Article: SBS Law Fraud Investigation Notice

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.